Baxter International Inc. Share Price Target ‘$43.83’, now 24.3% Upside Potential

DirectorsTalk Interviews

Baxter International Inc. which can be found using ticker (BAX) now have 12 confirmed analysts covering the stock with the consensus suggesting a rating of ‘hold’. The range between the high target price and low target price is between $54.00 and $39.00 with the average share target price sitting at $43.83. (at the time of writing). Now with the previous closing price of $35.25 this is indicating there is a potential upside of 24.3%. It’s also worth noting that there is a 50 day moving average of $40.06 and the 200 moving average now moves to $38.68. The market capitalization for the company is 17.85B. The stock price for the company is currently $35.02 USD

The potential market cap would be $22,189,160,333 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of -, revenue per share of $29.39 and a 3.54% return on assets.

Baxter International Inc., through its subsidiaries, provides a portfolio of essential healthcare products. The Company’s segments include Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia-Pacific), and Hillrom. The Americas, EMEA and APAC segments provide a portfolio of essential healthcare products, including acute and chronic dialysis therapies; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals, and surgical hemostat and sealant products. The Hillrom segment provides digital and connected care solutions and collaboration tools, including smart bed systems, patient monitoring and diagnostic technologies, respiratory health devices and advanced equipment for the surgical space. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices and by patients at home under physician supervision.

Share on:
Find more news, interviews, share price & company profile here for:

    BlackRock American Income Trust posts 2.5% NAV gain in May

    BlackRock American Income Trust plc reported a 2.5% NAV increase and 3.8% share price gain in May 2025. Strong performance in financials offset weaker energy positions.

    Avation reports strong trading and fleet expansion

    Avation has provided a trading update confirming continued fleet growth, strong rent collections, and improved aircraft values. All aircraft remain leased, with new deliveries scheduled through 2028 and further acquisitions under consideration.

    Versarien extends graphene licensing deal with Montana

    Versarien Plc has extended its licensing agreements with Montana Química LTDA for the use of its Polygrene™ graphene thermoplastic compounds in South America.

    Aptamer Group raises £2m to fund growth

    Aptamer Group plc has raised £2.0 million (before expenses) via a placing of new ordinary shares at 0.3p per share, representing a 21.1% discount.

    Marlowe publishes FY25 Annual Report following strategic transformation

    Marlowe has released its annual report and financial statements for the year ended 31 March 2025. The Group reports £304.5 million in continuing revenue, a £150 million special dividend, and a £75 million share buyback programme.

    Avation signs six-year lease agreement with PNG Air

    Avation has signed a new six-year lease with PNG Air for an ATR 72-600 aircraft, currently operated by Mandarin Airlines.

      Search

      Search